论文部分内容阅读
目的探讨剖宫产同时行子宫肌瘤剔除术的安全性及可行性。方法回顾性分析151例剖宫产同时行子宫肌瘤剔除术患者及同期174例妊娠未合并子宫肌瘤仅行剖宫产术患者的临床资料。结果剖宫产同时剔除子宫肌瘤组在年龄、术中宫缩剂的使用较对照组有显著性差异(P<0.01)。但两组患者在住院天数、手术时间、术中出血、术后血红蛋白下降、术后红细胞比容(HCT)下降及术后恢复均无明显差异。结论根据患者的情况,由有经验的产科医师在剖宫产同时剔除子宫肌瘤并不增加手术风险,是安全可行的。
Objective To investigate the safety and feasibility of uterine myomectomy in cesarean section. Methods The clinical data of 151 cases of cesarean section with uterine myomectomy and 174 cases of pregnancy without uterine fibroids were retrospectively analyzed. Results The use of uterine fibroids in cesarean section at the same time was significantly different from that in the control group (P<0.01). However, there was no significant difference between the two groups in the days of hospitalization, operation time, intraoperative hemorrhage, postoperative hemoglobin decline, postoperative hematocrit (HCT) decline, and postoperative recovery. Conclusions According to the patient’s condition, it is safe and feasible for experienced obstetricians to remove uterine fibroids at the same time as cesarean section without increasing the risk of surgery.